Insulet (PODD) Non-Current Assets (2010 - 2026)
Insulet (PODD) posted Non-Current Assets of $1.3 billion for Q1 2026, little changed on a QoQ basis from $1.3 billion in Q4 2025, and up 7.47% year-over-year from $1.2 billion in Q1 2025.
Insulet (PODD) Non-Current Assets (2010 - 2026) Analysis & Trends
Insulet's Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.
- Quarterly Non-Current Assets rose 7.47% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 4.93% YoY) and the FY2025 annual result came in at $1.3 billion, up 6.69% from the prior year.
- Non-Current Assets was $1.3 billion for Q1 2026 at Insulet, roughly flat from $1.3 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.3 billion in Q1 2026 and bottomed at $783.8 million in Q1 2022.
- A 5-year average of $1.1 billion and a median of $1.0 billion in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 30.33% — and 2025, when it grew 0.46%.
- Insulet's Non-Current Assets stood at $937.1 million in 2022, then advanced by 7.28% to $1.0 billion in 2023, then climbed by 19.01% to $1.2 billion in 2024, then rose by 6.69% to $1.3 billion in 2025, then increased by 0.1% to $1.3 billion in 2026.
- Business Quant data shows PODD's Non-Current Assets at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.17 Bn |
| Jun 30, 2025 | 1.19 Bn |
| Mar 31, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.01 Bn |
| Dec 31, 2023 | 1.01 Bn |
| Sep 30, 2023 | 996.60 Mn |
| Jun 30, 2023 | 964.30 Mn |
| Mar 31, 2023 | 959.10 Mn |
| Dec 31, 2022 | 937.10 Mn |
| Sep 30, 2022 | 837.10 Mn |
| Jun 30, 2022 | 804.60 Mn |
| Mar 31, 2022 | 783.80 Mn |
| Dec 31, 2021 | 719.00 Mn |
| Sep 30, 2021 | 692.00 Mn |
| Jun 30, 2021 | 670.80 Mn |